These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35094650)
1. Thrombophilic risk factors and ABO blood group profile for arteriovenous access failure in end stage kidney disease patients: a single-center experience. Anapalli SR; N HD; Sarma P; Srikanth L; V SK Ren Fail; 2022 Dec; 44(1):34-42. PubMed ID: 35094650 [TBL] [Abstract][Full Text] [Related]
2. The influence of thrombophilic risk factors on vascular access survival in chronic dialysis patients in a retrospective evaluation. Klamroth R; Orlovic M; Fritsche I; Seibt S; Seibt F; Wegscheider K; Landgraf H Vasa; 2013 Jan; 42(1):32-9. PubMed ID: 23385224 [TBL] [Abstract][Full Text] [Related]
3. Thrombophilia and arteriovenous fistula survival in ESRD. Salmela B; Hartman J; Peltonen S; Albäck A; Lassila R Clin J Am Soc Nephrol; 2013 Jun; 8(6):962-8. PubMed ID: 23411429 [TBL] [Abstract][Full Text] [Related]
4. Thrombophilia and the risk for hemodialysis vascular access thrombosis. Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with functional arteriovenous fistula at hemodialysis start and arteriovenous fistula non-use in a single-center cohort. Chung EY; Knagge D; Cheung S; Sun J; Heath L; McColl H; Guo H; Gray L; Srivastava T; Sandy J; McGinn S; Fisher C J Vasc Access; 2022 Jul; 23(4):558-566. PubMed ID: 33752497 [TBL] [Abstract][Full Text] [Related]
6. Hemodialysis duration, human platelet antigen HPA-3 and IgA isotype of anti-β2glycoprotein I antibodies are associated with native arteriovenous fistula failure in Tunisian hemodialysis patients. Hadhri S; Rejeb MB; Belarbia A; Achour A; Skouri H Thromb Res; 2013 May; 131(5):e202-9. PubMed ID: 23538147 [TBL] [Abstract][Full Text] [Related]
7. Predictive Factors for Unsuccessful Use of Arteriovenous Fistula in a Population of End-Stage Renal Disease Patients in Southeastern Mexico. Martinez-Mier G; Camargo-Diaz C; Urbina-Velazquez MA; Avila-Pardo SF Ann Vasc Surg; 2020 Jan; 62():304-309. PubMed ID: 31449952 [TBL] [Abstract][Full Text] [Related]
8. Coagulation, thrombophilia and patency of arteriovenous fistula in children undergoing haemodialysis compared with healthy volunteers: a prospective analysis. Fadel FI; Elshamaa MF; Abdel-Rahman SM; Thabet EH; Kamel S; Kandil D; Ibrahim MH; El-Ahmady M Blood Coagul Fibrinolysis; 2016 Mar; 27(2):190-8. PubMed ID: 26829282 [TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142 [TBL] [Abstract][Full Text] [Related]
10. A multicentre analysis of the outcome of arteriovenous fistula in maintenance haemodialysis. Jothi S; Kg H; Lesley N; Vijayan M; Haridas Anupama S; Mathew M; Parthasarathy R; Sundarajan S; P N; Kumaraswamy L; Abraham G Semin Dial; 2020 Sep; 33(5):388-393. PubMed ID: 32820840 [TBL] [Abstract][Full Text] [Related]
12. Analyses of hemodialysis arteriovenous fistula geometric configuration and its associations with maturation and reintervention. He Y; Northrup H; Roy-Chaudhury P; Cheung AK; Berceli SA; Shiu YT J Vasc Surg; 2021 May; 73(5):1778-1786.e1. PubMed ID: 33091518 [TBL] [Abstract][Full Text] [Related]
13. Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study. Allon M; Imrey PB; Cheung AK; Radeva M; Alpers CE; Beck GJ; Dember LM; Farber A; Greene T; Himmelfarb J; Huber TS; Kaufman JS; Kusek JW; Roy-Chaudhury P; Robbin ML; Vazquez MA; Feldman HI; Am J Kidney Dis; 2018 May; 71(5):677-689. PubMed ID: 29398178 [TBL] [Abstract][Full Text] [Related]
14. Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up. Grupp C; Troche-Polzien I; Stock J; Bramlage C; Müller GA; Koziolek M PLoS One; 2019; 14(9):e0222102. PubMed ID: 31539375 [TBL] [Abstract][Full Text] [Related]
15. Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia. Fekih-Mrissa N; Klai S; Bafoun A; Nciri B; Hmida J; Gritli N Ther Apher Dial; 2011 Feb; 15(1):40-3. PubMed ID: 21272251 [TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Prakash R; Miller CC; Suki WN Am J Kidney Dis; 1995 Aug; 26(2):347-52. PubMed ID: 7645540 [TBL] [Abstract][Full Text] [Related]
17. Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients. Kirkpantur A; Arici M; Altun B; Yilmaz MI; Cil B; Aki T; Bakkaloglu M; Turgan C Blood Purif; 2008; 26(4):322-32. PubMed ID: 18487877 [TBL] [Abstract][Full Text] [Related]
18. The natural history of autogenous radio-cephalic wrist arteriovenous fistulas of haemodialysis patients: a prospective observational study. Basile C; Ruggieri G; Vernaglione L; Montanaro A; Giordano R Nephrol Dial Transplant; 2004 May; 19(5):1231-6. PubMed ID: 14993512 [TBL] [Abstract][Full Text] [Related]
20. The presence of PAI-1 4G/5G and ACE DD genotypes increases the risk of early-stage AVF thrombosis in hemodialysis patients. Güngör Y; Kayataş M; Yıldız G; Özdemir Ö; Candan F Ren Fail; 2011; 33(2):169-75. PubMed ID: 21332339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]